Erratum: Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans

被引：0
|
作者：
A Gaedigk
A Bhathena
L Ndjountché
R E Pearce
S M Abdel-Rahman
S W Alander
L DiAnne Bradford
J Steven Leeder
机构：
来源：
The Pharmacogenomics Journal | 2005年 / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Correction to: The Pharmacogenomics Journal (2005) 5, 173–182. doi:10.1038/sj.tpj.6500305 The authors wish to add an additional co-author as indicated in bold: A Gaedigk, A Bhathena, L Ndjountché, RE Pearce, SM Abdel-Rahman, SW Alander, L DiAnne Bradford, PK Rogan3 and J Steven Leeder With the following affiliation: 3 Laboratory of Human Molecular Genetics, Children's Mercy Hospital & Clinics, Kansas City, MO, USA.
引用
收藏
页码：276 / 276
相关论文
共 50 条
  • [1] Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans
    A Gaedigk
    A Bhathena
    L Ndjountché
    R E Pearce
    S M Abdel-Rahman
    S W Alander
    L DiAnne Bradford
    J Steven Leeder
    The Pharmacogenomics Journal, 2005, 5 : 173 - 182
  • [2] Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans
    Gaedigk, A
    Bhathena, A
    Ndjountché, L
    Pearce, RE
    Abdel-Rahman, SM
    Alander, SW
    Bradford, LD
    Leeder, JS
    PHARMACOGENOMICS JOURNAL, 2005, 5 (03): : 173 - 182
  • [3] Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans (vol 5, pg 173, 2005)
    Gaedigk, A
    Bhathena, A
    Ndjountché, L
    Pearce, RE
    Abdel-Rahman, SM
    Alander, SW
    Bradford, LD
    Leeder, JS
    PHARMACOGENOMICS JOURNAL, 2005, 5 (04): : 276 - 276
  • [4] Cytochrome P4502D6 (CYP2D6) bioelectrode for fluoxetine
    Iwuoha, EI
    Wilson, A
    Howel, M
    Mathebe, NGR
    Montane-Jaime, K
    Narinesingh, D
    Guiseppi-Elie, A
    ANALYTICAL LETTERS, 2004, 37 (05) : 929 - 941
  • [5] Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity:: Characterization of gene duplication events
    Gaedigk, A.
    Ndjountche, L.
    Divakaran, K.
    Bradford, L. DiAnne
    Zineh, I.
    Oberlander, T. F.
    Brousseau, D. C.
    McCarver, D. G.
    Johnson, J. A.
    Alander, S. W.
    Riggs, K. Wayne
    Leeder, J. Steven
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (02) : 242 - 251
  • [6] Inhibition of cytochrome P4502D6 (CYP2D6) by terbinafine (TER) in vitro.
    Abdel-Rahman, SM
    Marcucci, K
    Boge, T
    Gotschall, RR
    Kearns, GL
    Leeder, JS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 135 - 135
  • [7] The in vitro interaction of dexmedetomidine with human liver microsomal cytochrome P4502D6 (CYP2D6)
    Rodrigues, AD
    Roberts, EM
    DRUG METABOLISM AND DISPOSITION, 1997, 25 (05) : 651 - 655
  • [8] Accuracy of cytochrome P4502D6 (CYP2D6): Phenotype assignment from genotyping data.
    Gaedigk, A
    Gotschall, RR
    Forbes, NS
    Simon, SD
    Leeder, JS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 139 - 139
  • [9] Molecular modelling of cytochrome P4502D6 (CYP2D6) based on an alignment with CYP102: Structural studies on specific CYP2D6 substrate metabolism
    Lewis, DFV
    Eddershaw, PJ
    Goldfarb, PS
    Tarbit, MH
    XENOBIOTICA, 1997, 27 (04) : 319 - 339
  • [10] Identification and characterization of cytochrome P4502D6*56B (CYP2D6*56B), a novel allele associated with the poor metabolizer phenotype.
    Gaedigk, A.
    Eklund, J. D.
    Pearce, R. E.
    Leeder, J. S.
    Alander, S. W.
    Bradford, L. D.
    Kennedy, M. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S85 - S85
12345